You are here

  • Home
  • Archive
  • Volume 12, Issue 9
  • Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study

 

Online download statistics by month:

Online download statistics by month: September 2024 to April 2025

AbstractFullPdf
Sep 20241001019
Oct 202410361044366
Nov 2024311312149
Dec 2024311314114
Jan 2025271271117
Feb 2025205206103
Mar 2025207207185
Apr 2025167169108
Total260826241151